PT1032390E - Formulacao anestesica - Google Patents

Formulacao anestesica

Info

Publication number
PT1032390E
PT1032390E PT98954639T PT98954639T PT1032390E PT 1032390 E PT1032390 E PT 1032390E PT 98954639 T PT98954639 T PT 98954639T PT 98954639 T PT98954639 T PT 98954639T PT 1032390 E PT1032390 E PT 1032390E
Authority
PT
Portugal
Prior art keywords
saccharide
amount
additional non
anesthetic agent
anesthetic formulation
Prior art date
Application number
PT98954639T
Other languages
English (en)
Portuguese (pt)
Inventor
Stephen Darwin Brown
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9724506.2A external-priority patent/GB9724506D0/en
Priority claimed from GBGB9818109.2A external-priority patent/GB9818109D0/en
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Publication of PT1032390E publication Critical patent/PT1032390E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
PT98954639T 1997-11-19 1998-11-19 Formulacao anestesica PT1032390E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9724506.2A GB9724506D0 (en) 1997-11-19 1997-11-19 Levobupivacaine and its use
GBGB9818109.2A GB9818109D0 (en) 1998-08-19 1998-08-19 Anaesthetic Formulation

Publications (1)

Publication Number Publication Date
PT1032390E true PT1032390E (pt) 2004-04-30

Family

ID=26312628

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98954639T PT1032390E (pt) 1997-11-19 1998-11-19 Formulacao anestesica

Country Status (17)

Country Link
US (1) US5932597A (enExample)
EP (1) EP1032390B1 (enExample)
JP (1) JP2001522888A (enExample)
KR (1) KR100695588B1 (enExample)
CN (1) CN1131033C (enExample)
AT (1) ATE253913T1 (enExample)
AU (1) AU740914B2 (enExample)
BR (1) BR9814883A (enExample)
CA (1) CA2308495C (enExample)
DE (1) DE69819770T2 (enExample)
DK (1) DK1032390T3 (enExample)
ES (1) ES2209217T3 (enExample)
HU (1) HU228143B1 (enExample)
IL (1) IL135922A0 (enExample)
NO (1) NO328684B1 (enExample)
PT (1) PT1032390E (enExample)
WO (1) WO1999025349A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9824161D0 (en) * 1998-11-04 1998-12-30 Darwin Discovery Ltd Drug formulation
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
SI1575569T1 (sl) 2002-12-13 2010-12-31 Durect Corp Oralni sistem dostave zdravila, ki obsega visokoviskozne tekoče nosilne materiale
SI2767292T1 (sl) 2004-09-17 2017-01-31 Durect Corporation Pripravek, ki vsebuje lokalni anestetik SAIB, s podaljšanim sproščanjem
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
EP2117521B1 (en) 2006-11-03 2012-06-27 Durect Corporation Transdermal delivery systems comprising bupivacaine
EP2067471B1 (en) * 2007-12-06 2018-02-14 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
SG11201407323WA (en) * 2012-05-10 2014-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of local pain
CA2905131A1 (en) 2013-03-15 2014-09-18 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
EP3331508B1 (en) * 2015-07-13 2024-08-14 Neon Laboratories Ltd. Hyperbaric solution injection of levobupivacaine hydrochloride comprising levobupivacaine hydrochloride
JP7258561B2 (ja) 2016-07-06 2023-04-17 オリエント ファーマ シーオー．，エルティーディー． 薬物組成物、バリヤー層及び薬物層を有している経口投与形態
KR20220140711A (ko) 2020-01-13 2022-10-18 듀렉트 코퍼레이션 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법
KR20230145053A (ko) 2021-01-12 2023-10-17 듀렉트 코퍼레이션 지속 방출 약물 전달 시스템 및 관련 방법
WO2025175174A1 (en) * 2024-02-14 2025-08-21 The Children's Medical Center Corporation 2'-6'-pipecoloxylidide as a sensory-selective anesthetic

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8802564D0 (sv) * 1988-07-08 1988-07-08 Astra Ab New synergistic preparations and a new method of alleviation of pain
GB9321061D0 (en) * 1993-10-13 1993-12-01 Chiroscience Ltd Analgestic agent and its use
EP0727210B1 (en) * 1993-10-13 2001-12-19 Darwin Discovery Limited Analgesic agent and its use

Also Published As

Publication number Publication date
CA2308495C (en) 2009-01-06
AU1168499A (en) 1999-06-07
HUP0004665A2 (hu) 2001-04-28
WO1999025349A1 (en) 1999-05-27
CA2308495A1 (en) 1999-05-27
NO20002545L (no) 2000-05-18
KR20010032241A (ko) 2001-04-16
BR9814883A (pt) 2000-10-03
EP1032390B1 (en) 2003-11-12
AU740914B2 (en) 2001-11-15
JP2001522888A (ja) 2001-11-20
ATE253913T1 (de) 2003-11-15
DK1032390T3 (da) 2004-03-15
DE69819770T2 (de) 2004-09-23
HK1026848A1 (en) 2000-12-29
DE69819770D1 (de) 2003-12-18
NO328684B1 (no) 2010-04-26
CN1279607A (zh) 2001-01-10
NO20002545D0 (no) 2000-05-18
KR100695588B1 (ko) 2007-03-14
EP1032390A1 (en) 2000-09-06
HUP0004665A3 (en) 2004-05-28
HU228143B1 (en) 2012-12-28
US5932597A (en) 1999-08-03
IL135922A0 (en) 2001-05-20
CN1131033C (zh) 2003-12-17
ES2209217T3 (es) 2004-06-16

Similar Documents

Publication Publication Date Title
DK1032390T3 (da) Anæstetisk formulering
BR0214184A (pt) Composições que contêm óleos que possuem gravidade especìfica mais alta que a gravidade especìfica da água
BR0207420A (pt) Processo e composições para desinfecção de superfìcies duras
BR0108828A (pt) Formulação de carboidrato (adjuvante pré-biótico) para aperfeiçoamento de resposta imuno
MXPA03006841A (es) 4-fluoro-n-indan-2-il-benzamida y su uso como producto farmaceutico.
BR0214264A (pt) Composição, processo de preparação da composição e seus usos
EP1068870A4 (en) ANTITUMORAL AGENTS
ATE179884T1 (de) Viskoelastische zusammensetzungen aus organischen fluorierten verbindungen
ATE367097T1 (de) Verwendung von füllstoffe als sättigungsmittel
EE03235B1 (et) Emulsioonvorm, selle valmistamise protsess ja kasutamine
AU2003298179A1 (en) Lens care composition and method
JP2001522888A5 (enExample)
DE60104872D1 (de) Stabilisierte ophthalmische wasserstoffperoxidlösung
RU2004102395A (ru) Жидкая композиция, включающая сложный эфир полиоксиэтиленсорбита и жирной кислоты
DK0666739T3 (da) Intravenøs opløsning som formindsker protein- og vandtab fra kroppen
ATE238803T1 (de) Pphospholipidkomplexe von proanthocyanidin a2 als antiatherosklerotische mittel
DE69326840D1 (de) Ophtalmische Zusammensetzungen enthaltenden Emedastine und ihre Verwendungzur Behandlung von allergischer Konjunktivitis
EP1420743A4 (en) CHOLESTEROL SULFATE AND AMINO SUGAR COMPOSITIONS FOR IMPROVING THE FUNCTION OF THE CORNEO LAYER OF EPIDERMA
DK0647129T3 (da) Præparat til topisk anvendelse
ATE333877T1 (de) Amlopidinbezylat-tabletten mit verbesserter stabilität
IT1265647B1 (it) Composizione farmaceutiche topiche per le allergie respiratorie
ES2189886T3 (es) Composicion farmaceutica para aplicacion topica.
ES2148315T3 (es) Composicion espesa fluidizable mediante esfuerzo cortante.
SE9003181D0 (sv) Use of heparin fraction
ATE311891T1 (de) Cytidin-diphosphocholin gegen diabetische neuropathie